These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2986544)

  • 1. In vitro activities of bismuth salts against rotaviruses and other enteric viruses.
    Ward RL; Sander DS; Knowlton DR
    Antimicrob Agents Chemother; 1985 Mar; 27(3):306-8. PubMed ID: 2986544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens.
    Pitz AM; Park GW; Lee D; Boissy YL; Vinjé J
    Gut Microbes; 2015; 6(2):93-100. PubMed ID: 25901890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sulfated colominic acid on enteric virus (rotavirus, poliovirus and coxsackievirus) infections in vitro.
    Konishi K; Gu Y; Hatano I; Ushijima H
    Jpn J Infect Dis; 2000 Apr; 53(2):62-6. PubMed ID: 10871916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that bismuth salts reduce invasion of epithelial cells by enteroinvasive bacteria.
    Gump DW; Nadeau OW; Hendricks GM; Meyer DH
    Med Microbiol Immunol; 1992; 181(3):131-43. PubMed ID: 1522823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori.
    Vogt K; Warrelmann M; Hahn H
    Zentralbl Bakteriol; 1989 Sep; 271(3):304-10. PubMed ID: 2803458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of bismuth and salicylate salts on the antibiotic susceptibility of Pseudomonas aeruginosa.
    Domenico P; O'Leary R; Cunha BA
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):170-5. PubMed ID: 1396732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts.
    Manhart MD
    Rev Infect Dis; 1990; 12 Suppl 1():S11-5. PubMed ID: 2406851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of rotavirus and enterovirus infections by tea extracts.
    Mukoyama A; Ushijima H; Nishimura S; Koike H; Toda M; Hara Y; Shimamura T
    Jpn J Med Sci Biol; 1991 Aug; 44(4):181-6. PubMed ID: 1668240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of human rotavirus, SA11 and other enteric viruses in effluent by disinfectants.
    Harakeh M; Butler M
    J Hyg (Lond); 1984 Aug; 93(1):157-63. PubMed ID: 6086748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison by plaque assay of bovine rotavirus and a bovine enterovirus-like agent.
    Archambault D; Roy RS; elAzhary MA; Dea S
    Vet Microbiol; 1986 Jul; 12(2):189-94. PubMed ID: 3018995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of bismuth-containing compounds.
    Lambert JR
    Rev Infect Dis; 1991; 13 Suppl 8():S691-5. PubMed ID: 1925310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro bile acid adsorption by bismuth subsalicylate and montmorillonite.
    Kocoshis SA; Ghent CN; Gryboski JD
    Dig Dis Sci; 1984 Dec; 29(12):1148-52. PubMed ID: 6499633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibacterial activity of bismuth subsalicylate.
    Cornick NA; Silva M; Gorbach SL
    Rev Infect Dis; 1990; 12 Suppl 1():S9-10. PubMed ID: 2305178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro anti-rotavirus activity of polyphenol compounds isolated from the roots of Glycyrrhiza uralensis.
    Kwon HJ; Kim HH; Ryu YB; Kim JH; Jeong HJ; Lee SW; Chang JS; Cho KO; Rho MC; Park SJ; Lee WS
    Bioorg Med Chem; 2010 Nov; 18(21):7668-74. PubMed ID: 20850329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of capsular polysaccharide and potentiation of aminoglycoside inhibition in gram-negative bacteria by bismuth subsalicylate.
    Domenico P; Landolphi DR; Cunha BA
    J Antimicrob Chemother; 1991 Dec; 28(6):801-10. PubMed ID: 1816178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pylori.
    Meyer JM; Ryu S; Pendland SL; Danziger LH
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1607-8. PubMed ID: 9210696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and serotyping of porcine rotaviruses and antigenic comparison with other rotaviruses.
    Bohl EH; Theil KW; Saif LJ
    J Clin Microbiol; 1984 Feb; 19(2):105-11. PubMed ID: 6321541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of subsalicylate bismuth on absorption of doxycycline.
    Ericsson CD; Feldman S; Pickering LK; Cleary TG
    JAMA; 1982 Apr; 247(16):2266-7. PubMed ID: 7040708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.
    McNulty CA; Dent J; Wise R
    Antimicrob Agents Chemother; 1985 Dec; 28(6):837-8. PubMed ID: 2935076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Antibiotic Neomycin Enhances Coxsackievirus Plaque Formation.
    Woods Acevedo MA; Erickson AK; Pfeiffer JK
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30787120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.